Beth Ellen Davis

机构：University of Saskatchewan, University of Virginia · ORCID：0000-0003-2867-0949

发表论文 177 篇 · 总被引 6705 次 · h-index 39

代表论文

Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses (2016 · Journal of Allergy and Clinical Immunology · 被引 143)
Sounding the alarmins—The role of alarmin cytokines in asthma (2022 · Allergy · 被引 138)
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma (2023 · European Respiratory Journal · 被引 73)
Allergen provocation tests in respiratory research: building on 50 years of experience (2022 · European Respiratory Journal · 被引 31)
Methacholine challenge testing: comparative pharmacology (2018 · Journal of Asthma and Allergy · 被引 26)
Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial (2024 · European Respiratory Journal · 被引 25)